Prudential discloses 6.7% stake in Palvella

Prudential Financial, Inc. reported beneficial ownership of common stock of Palvella Therapeutics, Inc. as of June 30, 2026.

Rhea-AI Filing Summary

Prudential Financial, Inc. reported beneficial ownership of common stock of Palvella Therapeutics, Inc. as of June 30, 2026. Prudential and its subsidiaries beneficially owned 962,374 shares of Palvella common stock, representing 6.7% of the class. Prudential reported 0 shares with sole voting or dispositive power, and 826,531 shares with shared voting power and 962,374 shares with shared dispositive power. The stake is held through subsidiaries including Jennison IA with 960,619 shares (6.7%) and PGIM Quantitative Solutions LLC with 1,755 shares. Prudential noted that its clients may have rights to receive dividends or sale proceeds related to these securities.

Key Figures

Beneficially owned shares: 962,374 shares Percent of class: 6.7% Shared voting power: 826,531 shares +4 more

7 metrics

Beneficially owned shares 962,374 shares Common stock of Palvella Therapeutics beneficially owned by Prudential and subsidiaries

Percent of class 6.7% Portion of Palvella common stock class beneficially owned by Prudential

Shared voting power 826,531 shares Shares of Palvella common where Prudential has shared power to vote

Shared dispositive power 962,374 shares Shares of Palvella common where Prudential has shared power to dispose

Jennison IA holdings 960,619 shares Palvella shares beneficially owned via Prudential subsidiary Jennison IA (6.7%)

PGIM Quant Solutions holdings 1,755 shares Palvella shares beneficially owned via PGIM Quantitative Solutions LLC

Date of beneficial ownership 06/30/2026 Date as of which Palvella ownership figures are reported

Key Terms

beneficially owned, shared voting power, shared dispositive power, Parent Holding Company, +1 more

5 terms

beneficially owned financial

"Amount beneficially owned: 962,374 (b) | Percent of class: 6.7 %"

Beneficially owned describes securities or assets where a person has the economic rights and control—such as the right to receive dividends and to direct voting—even if legal title is held in another name. Think of it like having the keys and using a car that’s registered to someone else: you get the benefits and make decisions. Investors care because beneficial ownership reveals who truly controls value and voting power, affecting corporate decisions and takeover dynamics.

shared voting power financial

"Shared power to vote or to direct the vote: 826,531"

Shared voting power occurs when two or more parties jointly have the right to vote or decide how a block of company shares is cast, like co-owners who must agree before moving a piece of furniture. Investors care because who controls voting rights affects board elections, major corporate decisions and takeover outcomes, and shared control can alter regulatory disclosures and the practical influence any holder has over a company’s direction and value.

shared dispositive power financial

"Shared power to dispose or to direct the disposition of: 962,374"

Parent Holding Company financial

"Prudential Financial, Inc. is a Parent Holding Company and the indirect parent"

Investment Company Act of 1940 regulatory

"investment company registered under the Investment Company Act of 1940"

A U.S. federal law that sets the rulebook for pooled investment vehicles such as mutual funds, exchange-traded funds and similar money managers, requiring them to register with regulators, disclose holdings and fees, limit conflicts of interest, and follow governance standards. It matters to investors because these protections and transparency rules act like a referee and scoreboard, helping people compare funds, trust that managers follow fair practices, and spot hidden costs or risks.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What ownership in Palvella Therapeutics (PVLA) did Prudential Financial report?

Prudential Financial reported beneficial ownership of 962,374 shares of Palvella Therapeutics common stock, representing 6.7% of the outstanding class as of June 30, 2026.

How much voting power does Prudential Financial have in Palvella Therapeutics (PVLA)?

Prudential reported 0 shares with sole voting power and 826,531 shares with shared voting power in Palvella Therapeutics, reflecting its influence being exercised jointly, not individually.

Which Prudential subsidiaries hold Palvella Therapeutics (PVLA) shares and how many?

Prudential identified Jennison IA as holding 960,619 shares (6.7%) and PGIM Quantitative Solutions LLC as holding 1,755 shares of Palvella Therapeutics common stock.

What does 6.7% beneficial ownership in PVLA mean in this filing?

Beneficial ownership of 6.7% means Prudential and its subsidiaries are deemed to beneficially own that portion of Palvella’s common stock, considering their power to vote or dispose of 962,374 shares on behalf of clients.

Do Prudential’s clients have rights to Palvella Therapeutics (PVLA) dividends or sale proceeds?

Yes. Prudential stated that its clients may have the right to receive or direct dividends and proceeds from the sale of the Palvella shares referenced in this Schedule 13G.

Does Prudential Financial have sole dispositive power over its Palvella Therapeutics (PVLA) stake?

No. Prudential reported 0 shares with sole dispositive power and 962,374 shares with shared dispositive power, indicating decisions are made jointly, often for clients’ accounts.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 08/10/2026 - 02:12 PM EDT Learn about SEC filing dates

SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

SCHEDULE 13G

UNDER THE SECURITIES EXCHANGE ACT OF 1934

PALVELLA THERAPEUTICS, INC.

(Name of Issuer)

Common

(Title of Class of Securities)

697947109

(CUSIP Number)

06/30/2026

(Date of Event Which Requires Filing of this Statement)

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

Rule 13d-1(b)

Rule 13d-1(c)

Rule 13d-1(d)

schemaVersion:

SCHEDULE 13G

CUSIP Number(s): 697947109

1

Names of Reporting Persons

PRUDENTIAL FINANCIAL INC

2

Check the appropriate box if a member of a Group (see instructions)

(a)
(b)

3

Sec Use Only

4

Citizenship or Place of Organization

NEW JERSEY

Number of Shares Beneficially Owned by Each Reporting Person With:

5	Sole Voting Power 0.00
6	Shared Voting Power 826,531.00
7	Sole Dispositive Power 0.00
8	Shared Dispositive Power 962,374.00

9

Aggregate Amount Beneficially Owned by Each Reporting Person

962,374.00

10

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

11

Percent of class represented by amount in row (9)

6.7 %

12

Type of Reporting Person (See Instructions)

HC

SCHEDULE 13G

Item 1.
(a)	Name of issuer: PALVELLA THERAPEUTICS, INC.
(b)	Address of issuer's principal executive offices: 353 W. LANCASTER AVENUE, SUITE 200, WAYNE, PENNSYLVANIA, 19087.
Item 2.
(a)	Name of person filing: Prudential Financial, Inc.
(b)	Address or principal business office or, if none, residence: 751 Broad Street Newark, New Jersey 07102-3777
(c)	Citizenship: New Jersey
(d)	Title of class of securities: Common
(e)	CUSIP Number(s): 697947109
Item 3.	If this statement is filed pursuant to §§ 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:
(a)	Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o);
(b)	Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c);
(c)	Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c);
(d)	Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8);
(e)	An investment adviser in accordance with § 240.13d-1(b)(1)(ii)(E);
(f)	An employee benefit plan or endowment fund in accordance with § 240.13d-1(b)(1)(ii)(F);
(g)	A parent holding company or control person in accordance with § 240.13d-1(b)(1)(ii)(G);
(h)	A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);
(i)	A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);
(j)	A non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J). If filing as a non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J), please specify the type of institution:
(k)	Group, in accordance with Rule 240.13d-1(b)(1)(ii)(K).
Item 4.	Ownership
(a)	Amount beneficially owned: 962,374
(b)	Percent of class: 6.7 %
(c)	Number of shares as to which the person has:
	(i) Sole power to vote or to direct the vote: 0
	(ii) Shared power to vote or to direct the vote: 826,531
	(iii) Sole power to dispose or to direct the disposition of: 0
	(iv) Shared power to dispose or to direct the disposition of: 962,374
Item 5.	Ownership of 5 Percent or Less of a Class.
	Not Applicable
Item 6.	Ownership of more than 5 Percent on Behalf of Another Person.
	If any other person is known to have the right to receive or the power to direct the receipt of dividends from, or the proceeds from the sale of, such securities, a statement to that effect should be included in response to this item and, if such interest relates to more than 5 percent of the class, such person should be identified. A listing of the shareholders of an investment company registered under the Investment Company Act of 1940 or the beneficiaries of employee benefit plan, pension fund or endowment fund is not required. Our clients may have the right to receive or the power to direct the receipt of dividends from, or the proceeds from the sale of, such securities which are the subject of this filing.
Item 7.	Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person.
	If a parent holding company has filed this schedule, pursuant to Rule 13d-1(b)(ii)(G), so indicate under Item 3(g) and attach an exhibit stating the identity and the Item 3 classification of the relevant subsidiary. If a parent holding company has filed this schedule pursuant to Rule 13d-1(c) or Rule 13d-1(d), attach an exhibit stating the identification of the relevant subsidiary. Prudential Financial, Inc. is a Parent Holding Company and the indirect parent of the following subsidiaries, who are the beneficial owners of the number and percentage of securities which are the subject of this filing as set forth next to their names: Subsidiaries Number of shares Percentage Jennison IA 960,619 6.7 PGIM Quantitative Solutions LLC IA 1,755 0.0
Item 8.	Identification and Classification of Members of the Group.
	Not Applicable
Item 9.	Notice of Dissolution of Group.
	Not Applicable

Item 10.

Certifications:

By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under § 240.14a-11.

SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

PRUDENTIAL FINANCIAL INC

Signature:	/s/ Richard Baker
Name/Title:	Second Vice President
Date:	08/10/2026